Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ALIZY | CMWAY |
|---|---|---|
| Price | $47.03 | $105.94 |
| Change today | ▲ 0.43% | ▲ 0.12% |
| Market cap | $177.62B | $176.90B |
| Return, 3 months | -2.3% | -6.0% |
| Return, year to date | +6.9% | +2.5% |
| Return, 1 year | +15.8% | -3.3% |
| P/E (TTM) | 13.2 | 24.0 |
| P/B | 2.5 | 3.2 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 4.26% | 3.30% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 35 | 41 |
| 30-day volatility | 24.9% | 24.1% |
| Max drawdown, 1 year | -13.6% | -20.0% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
